Literature DB >> 24078629

Early B-cell factor 1 regulates the expansion of B-cell progenitors in a dose-dependent manner.

Josefine Åhsberg1, Jonas Ungerbäck, Tobias Strid, Eva Welinder, Jenny Stjernberg, Malin Larsson, Hong Qian, Mikael Sigvardsson.   

Abstract

Transcription factor doses are of importance for normal and malignant B-lymphocyte development; however, the understanding of underlying mechanisms and functional consequences of reduced transcription factor levels is limited. We have analyzed progenitor and B-lineage compartments in mice carrying heterozygote mutations in the E2a, Ebf1, or Pax5 gene. Although lymphoid progenitors from Ebf1 or Pax5 heterozygote mice were specified and lineage-restricted in a manner comparable with Wt progenitors, this process was severely impaired in E2a heterozygote mutant mice. This defect was not significantly enhanced upon combined deletion of E2a with Ebf1 or Pax5. Analysis of the pre-B-cell compartment in Ebf1 heterozygote mice revealed a reduction in cell numbers. These cells expressed Pax5 and other B-lineage-associated genes, and global gene expression analysis suggested that the reduction of the pre-B-cell compartment was a result of impaired pre-B-cell expansion. This idea was supported by a reduction in IL2Rα-expressing late pre-B-cells as well as by cell cycle analysis and by the finding that the complexity of the VDJ rearrangement patterns was comparable in Wt and Ebf1(+/-) pre-B-cells, although the number of progenitors was reduced. Heterozygote deletion of Ebf1 resulted in impaired response to IL7 in vitro and reduced expression levels of pre-BCR on the cell surface, providing possible explanations for the observed stage-specific reduction in cellular expansion. Thus, transcription factor doses are critical for specification as well as expansion of B-lymphoid progenitors, providing increased insight into the molecular regulation of B-cell development.

Entities:  

Keywords:  Development; Differentiation; Immunology; Lymphocyte; Transcription Factors

Mesh:

Substances:

Year:  2013        PMID: 24078629      PMCID: PMC3829190          DOI: 10.1074/jbc.M113.506261

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Flk2+ common lymphoid progenitors possess equivalent differentiation potential for the B and T lineages.

Authors:  Holger Karsunky; Matthew A Inlay; Thomas Serwold; Deepta Bhattacharya; Irving L Weissman
Journal:  Blood       Date:  2008-04-18       Impact factor: 22.113

2.  Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A.

Authors:  M O'Riordan; R Grosschedl
Journal:  Immunity       Date:  1999-07       Impact factor: 31.745

3.  Commitment to the B-lymphoid lineage depends on the transcription factor Pax5.

Authors:  S L Nutt; B Heavey; A G Rolink; M Busslinger
Journal:  Nature       Date:  1999-10-07       Impact factor: 49.962

4.  E2A proteins maintain the hematopoietic stem cell pool and promote the maturation of myelolymphoid and myeloerythroid progenitors.

Authors:  Craig L Semerad; Elinore M Mercer; Matthew A Inlay; Irving L Weissman; Cornelis Murre
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-30       Impact factor: 11.205

5.  E2A proteins promote development of lymphoid-primed multipotent progenitors.

Authors:  Sheila Dias; Robert Månsson; Sandeep Gurbuxani; Mikael Sigvardsson; Barbara L Kee
Journal:  Immunity       Date:  2008-07-31       Impact factor: 31.745

6.  Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors.

Authors:  César Cobaleda; Wolfram Jochum; Meinrad Busslinger
Journal:  Nature       Date:  2007-09-12       Impact factor: 49.962

7.  B-lineage commitment prior to surface expression of B220 and CD19 on hematopoietic progenitor cells.

Authors:  Robert Mansson; Sasan Zandi; Kristina Anderson; Inga-Lill Martensson; Sten Eirik W Jacobsen; David Bryder; Mikael Sigvardsson
Journal:  Blood       Date:  2008-05-21       Impact factor: 22.113

8.  E47 controls the developmental integrity and cell cycle quiescence of multipotential hematopoietic progenitors.

Authors:  Qi Yang; Lela Kardava; Anthony St Leger; Kathleen Martincic; Barbara Varnum-Finney; Irwin D Bernstein; Christine Milcarek; Lisa Borghesi
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

9.  EBF1 is essential for B-lineage priming and establishment of a transcription factor network in common lymphoid progenitors.

Authors:  Sasan Zandi; Robert Mansson; Panagiotis Tsapogas; Jenny Zetterblad; David Bryder; Mikael Sigvardsson
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

10.  Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia.

Authors:  Charles G Mullighan; Salil Goorha; Ina Radtke; Christopher B Miller; Elaine Coustan-Smith; James D Dalton; Kevin Girtman; Susan Mathew; Jing Ma; Stanley B Pounds; Xiaoping Su; Ching-Hon Pui; Mary V Relling; William E Evans; Sheila A Shurtleff; James R Downing
Journal:  Nature       Date:  2007-04-12       Impact factor: 49.962

View more
  11 in total

1.  Ebf1 heterozygosity results in increased DNA damage in pro-B cells and their synergistic transformation by Pax5 haploinsufficiency.

Authors:  Mahadesh A J Prasad; Jonas Ungerbäck; Josefine Åhsberg; Rajesh Somasundaram; Tobias Strid; Malin Larsson; Robert Månsson; Ayla De Paepe; Henrik Lilljebjörn; Thoas Fioretos; James Hagman; Mikael Sigvardsson
Journal:  Blood       Date:  2015-04-02       Impact factor: 22.113

Review 2.  Transcription factor networks in B-cell differentiation link development to acute lymphoid leukemia.

Authors:  Rajesh Somasundaram; Mahadesh A J Prasad; Jonas Ungerbäck; Mikael Sigvardsson
Journal:  Blood       Date:  2015-05-19       Impact factor: 22.113

3.  Ebf1 in DNA repair and leukemogenesis.

Authors:  Katia Georgopoulos
Journal:  Blood       Date:  2015-06-25       Impact factor: 22.113

4.  Early B Cell Progenitors Deficient for GON4L Fail To Differentiate Due to a Block in Mitotic Cell Division.

Authors:  Jennifer Y Barr; Renee X Goodfellow; Diana F Colgan; John D Colgan
Journal:  J Immunol       Date:  2017-04-05       Impact factor: 5.422

5.  Combined heterozygous loss of Ebf1 and Pax5 allows for T-lineage conversion of B cell progenitors.

Authors:  Jonas Ungerbäck; Josefine Åhsberg; Tobias Strid; Rajesh Somasundaram; Mikael Sigvardsson
Journal:  J Exp Med       Date:  2015-06-08       Impact factor: 14.307

6.  Mutant U2AF1-induced alternative splicing of H2afy (macroH2A1) regulates B-lymphopoiesis in mice.

Authors:  Sanghyun P Kim; Sridhar N Srivatsan; Monique Chavez; Cara L Shirai; Brian S White; Tanzir Ahmed; Michael O Alberti; Jin Shao; Ryan Nunley; Lynn S White; Jeff Bednarski; John R Pehrson; Matthew J Walter
Journal:  Cell Rep       Date:  2021-08-31       Impact factor: 9.423

7.  EBF1 and PAX5 control pro-B cell expansion via opposing regulation of the Myc gene.

Authors:  Rajesh Somasundaram; Christina T Jensen; Johanna Tingvall-Gustafsson; Josefine Åhsberg; Kazuki Okuyama; Mahadesh Prasad; James R Hagman; Xun Wang; Shamit Soneji; Tobias Strid; Jonas Ungerbäck; Mikael Sigvardsson
Journal:  Blood       Date:  2021-06-03       Impact factor: 22.113

8.  Epistatic interactions between mutations of TACI (TNFRSF13B) and TCF3 result in a severe primary immunodeficiency disorder and systemic lupus erythematosus.

Authors:  Rohan Ameratunga; Wikke Koopmans; See-Tarn Woon; Euphemia Leung; Klaus Lehnert; Charlotte A Slade; Jessica C Tempany; Anselm Enders; Richard Steele; Peter Browett; Philip D Hodgkin; Vanessa L Bryant
Journal:  Clin Transl Immunology       Date:  2017-10-20

Review 9.  Molecular Regulation of Differentiation in Early B-Lymphocyte Development.

Authors:  Mikael Sigvardsson
Journal:  Int J Mol Sci       Date:  2018-06-30       Impact factor: 5.923

10.  PAX5 is part of a functional transcription factor network targeted in lymphoid leukemia.

Authors:  Kazuki Okuyama; Tobias Strid; Jacob Kuruvilla; Rajesh Somasundaram; Susana Cristobal; Emma Smith; Mahadesh Prasad; Thoas Fioretos; Henrik Lilljebjörn; Shamit Soneji; Stefan Lang; Jonas Ungerbäck; Mikael Sigvardsson
Journal:  PLoS Genet       Date:  2019-08-05       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.